Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia M Davis

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Chemical Education|September 28, 2011
Forging Faculty Student Relationships at the College Level Using a Freshman Research ExperienceDavid C Forbes, Patricia M Davis
Clinical Immunology (Orlando, Fla.)|October 20, 2007
Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO inductionPatricia M Davis, Steven G Nadler, Dawn K Stetsko, et al.
The Journal of Rheumatology|September 6, 2007
Abatacept binds to the Fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicityPatricia M Davis, Ralph Abraham, Linda Xu, et al.
The Journal of Pediatrics|May 2, 2006
Are activated T cells regulators of bone metabolism in children with Crohn disease?Francisco A Sylvester, Patricia M Davis, Nancy Wyzga, et al.
Inflammatory Bowel Diseases|January 9, 2007
Natural history of bone metabolism and bone mineral density in children with inflammatory bowel diseaseFrancisco A Sylvester, Nancy Wyzga, Jeffrey S Hyams, et al.
Transplantation|March 21, 2009
Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturationRobert Latek, Catherine Fleener, Vahideh Lamian, et al.
Journal of Clinical Immunology|March 5, 2009
Abatacept does not induce direct gene expression changes in antigen-presenting cellsJulie A Carman, Patricia M Davis, Wen-Pin Yang, et al.
Cytometry. Part B, Clinical Cytometry|May 31, 2024
Synthetic abnormal mast cell particles successfully mimic neoplastic mast cells by flow cytometryPatricia M Davis, Eugene Ravkov, Martina de Geus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritisSuzanne J Suchard, Dawn K Stetsko, Patricia M Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2013
A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safetySuzanne J Suchard, Patricia M Davis, Selena Kansal, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Chemical Education|September 28, 2011
Forging Faculty Student Relationships at the College Level Using a Freshman Research ExperienceDavid C Forbes, Patricia M Davis
Clinical Immunology (Orlando, Fla.)|October 20, 2007
Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO inductionPatricia M Davis, Steven G Nadler, Dawn K Stetsko, et al.
The Journal of Rheumatology|September 6, 2007
Abatacept binds to the Fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicityPatricia M Davis, Ralph Abraham, Linda Xu, et al.
The Journal of Pediatrics|May 2, 2006
Are activated T cells regulators of bone metabolism in children with Crohn disease?Francisco A Sylvester, Patricia M Davis, Nancy Wyzga, et al.
Inflammatory Bowel Diseases|January 9, 2007
Natural history of bone metabolism and bone mineral density in children with inflammatory bowel diseaseFrancisco A Sylvester, Nancy Wyzga, Jeffrey S Hyams, et al.
Transplantation|March 21, 2009
Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturationRobert Latek, Catherine Fleener, Vahideh Lamian, et al.
Journal of Clinical Immunology|March 5, 2009
Abatacept does not induce direct gene expression changes in antigen-presenting cellsJulie A Carman, Patricia M Davis, Wen-Pin Yang, et al.
Cytometry. Part B, Clinical Cytometry|May 31, 2024
Synthetic abnormal mast cell particles successfully mimic neoplastic mast cells by flow cytometryPatricia M Davis, Eugene Ravkov, Martina de Geus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritisSuzanne J Suchard, Dawn K Stetsko, Patricia M Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2013
A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safetySuzanne J Suchard, Patricia M Davis, Selena Kansal, et al.
Pageof 2